JPRN-UMIN000002450已完成未知
Gemcitabine Plus Paclitaxel versus Gemcitabine alone in Patients with Recurrent or Advanced Urothelial Cancer previously Treated With Cisplatin-based Chemotherapy: A randomized Phase II study - Study of GP versus G regimen in patients with cisplatin-refractory urothelial cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. prior chemotherapy with gemcitabine or paclitaxel 2. patients with interstitial pneumoniae and pulmonary fibrosis 3. patients with body fluid with the necessity of drainage or severe edema 4. patients with brain metastasis with the necessity of treatment 5. active double cancer 6. severe or uncontrollable complications 7. patients with allergy to polyoxyethylene castor oil-contain drug (e.g., CDDP) or sclerosing castor oil-contain drug (e.g., injectable vitamins) 8. Not eligible for patients during Pregnancy or Lactation, and with the hope of pregnancy 9. Prior therapy is allowed if this is completed more than 28 days before study entry. 10. Otherwise, patients are judged to be not eligible by the attending doctor.
研究者
相似试验
已完成
不适用
ow-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastastic pancreatic cancer: A randomized phase II trialMetastatic pancreatic cancerJPRN-UMIN000024505Kindai University60
进行中（未招募）
不适用
Gemcitabine plus nab-paclitaxel versus folfirinox in patients with potentially resectable pancreatic carcinoma.Potentially resectable pancreatic cancerMedDRA version: 16.1Level: LLTClassification code 10033608Term: Pancreatic cancer resectableSystem Organ Class: 100000004864EUCTR2013-005087-25-ESFUNDACION HOSPITAL DE MADRID
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
2 期
Combination of Gemcitabine and Paclitaxel for urothelial carcinomarothelial carcionomaJPRN-UMIN000008357Saiseikai Yokohamashi Tobu Hospital40
未知
2 期
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinomaadvanced urothelial carcinomaJPRN-UMIN000001979Cancer Institute Hospital, Japanese Foundation for Cancer Research30